XJPX
7634
Market cap94mUSD
Jul 06, Last price
4,900.00JPY
1D
0.00%
1Q
-9.93%
Jan 2017
32.97%
IPO
171.74%
Name
Hoshi Iryo-Sanki Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hoshi Iryo-Sanki Co., Ltd., a Japanese firm, specializes in the production and distribution of pharmaceutical-grade medical oxygen and nitrous oxide. Its business activities are structured across five distinct divisions: Medical Gas, Home Healthcare, Medical Gas Equipment Construction, Nursing Care, and Facilities Nursing. The Medical Gas division primarily handles the sale of various medical gases, including oxygen and anesthetic gases. Through its Home Healthcare division, the company offers rental services for essential medical devices, such as oxygen concentrators for home therapy, continuous positive airway pressure (CPAP) machines, and home ventilators. The Medical Gas Equipment Construction segment is responsible for the planning, installation, and subsequent maintenance and inspection of medical gas piping systems. The Nursing Care division provides a comprehensive suite of services, encompassing the rental and sale of care-related products, home modifications, and direct nursing assistance through home visits and in-home care coordination. Lastly, the Facilities Nursing division manages and operates fee-based residential nursing homes and day care centers, along with other related services. Established in 1960, the company's main offices are situated in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||